Current views on the use of interferons in the treatment of polycythaemia vera
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2019, Vol 4, Issue 2
Abstract
Interferon alpha is a molecule associated with stimulation of immune system cells, resulting in an anti‐proliferative and immunomodulatory effect. It has been demonstrated that interferon reduces the number of platelets, leukocytes, and erythrocytes in patients suffering from chronic myeloproliferative diseases. In this paper, we present an overview of selected research evaluating the efficacy and adverse effects of various recombinant interferons used in the treatment of polycythaemia vera. We have analysed previously reported studies on the use of interferon. Interferon alfa‐2a was the first interferon approved for standard treatment of polycythaemia vera, while the next was pegylated interferon alfa‐2a. We also present recent results from studies on a newly modified molecule, ropeginterferon, a mono‐pegylated form of interferon alfa‐2b. Interferons reduce the number of phlebotomies required in patients with polycythaemia vera, accompanied by a resolution of typical disease symptoms. Treatment is well tolerated by the majority of patients. JRCD 2019; 4 (2): 34-36.
Authors and Affiliations
Anna Prochwicz, Elżbieta Szczepanek, Dorota Krochmalczyk
Keywords
Related Articles
- EP ID EP629301
- DOI 10.2041/jrcd.vol4no2.363
- Views 110
- Downloads 0
An adult patient with tetralogy of Fallot and anomalous left anterior descending artery after conduit type of repair (RCD code: IV‑2A.1)
Tetralogy of Fallot is one of the most common cyanotic congenital cardiac disease concerning 10% newborn with congenital heart failures. About 3% of those patients have anomalous left anterior descending coronary artery....
Heart in Fabry Disease
Fabry disease is one of the lysosomal storage disorders, that results from progressive multiorgan accumulation of glycoproteins. It is caused by mutations of the GLA gene, which encodes alpha-galactosidase A. The incide...
Eosinophilic myocarditis: Gardia lamblia infestation and Garcinia cambogia. Coincidence or causality? (RCD code: III‑1B.1.o)
Eosinophilic myocarditis is a rare form of myocardial inflammation that may lead to heart failure and death, if left untreated. A previously healthy 26-year-old man was admitted to the department with chest pain and dysp...
“Let (the hospital) serve!”. Pope John Paul II. Visit at the John Paul II Hospital in Krakow, 9 June 1997
This June, here in Krakow we witness two important anniversaries. First, our hospital, now called after Pope John Paul II, is already 100 years old. Secondly, 20 years have already passed since the visit on the hospital’...
Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death
We present the case of a young patient with significant left ventricular hypertrophy as a common representation of the hypertrophic cardiomyopathy (HCM) phenotype. The clinical presentation and diagnostic route of the di...